Drug or technology

Iohexol

2 developments in the corpus

Following this puts new work involving it at the top of your briefing, with a note saying why it is there. Links are taken from the source record, never inferred.

Latest

Everything in the corpus, newest first.

AUG 14, 2026 · INTERVENTIONAL STUDY

MediBeacon® Transdermal GFR System for the Evaluation of Kidney Function in Adults With Heart Failure

ClinicalTrials.gov

This is a small, single-centre feasibility study of a novel non-invasive device for GFR measurement in a specific population; no results are reported in this registry record.

PreliminaryIohexol NCT07349797 Heart Failure

Reported

Planned enrollment15

Primary outcome measureCorrelation of Transdermal Derived GFR (tGF…

Follow-up duration on study day10-24 hours

AUG 11, 2026 · PHASE 4 TRIAL

Mechanisms Underlying Hypotensive Response to ARB/NEP Inhibition - Aim 2

ClinicalTrials.gov

This is a completed mechanistic Phase 4 crossover study testing a hypothesis about bradykinin's role in ARB/NEP inhibitor hypotension in heart failure; no results are reported in this registry record.

PreliminaryIcatibant Iohexol LCZ 696

Reported

Planned enrollment80

Actual enrollment46

PhasePHASE 4